Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 22, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Telangiectatic osteosarcoma.

Nikhil A Sangle1, Lester J Layfield

  • 1Department of Pathology, University of Utah Health Sciences Center, 50 N Medical Dr, Salt Lake City, UT 84132, USA. nikhil_sangle@yahoo.com

Archives of Pathology & Laboratory Medicine
|May 1, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytomorphologic Predictors of Adenoid Cystic Carcinoma: Insights From a Multi-Center Logistic Regression Study.

Diagnostic cytopathology·2026
Same author

The Milan System SUMP Category: 5-Year Diagnostic Performance.

Diagnostic cytopathology·2025
Same author

Spinal fusion properties of mechanically-reinforced, osteomodulatory chitosan hydrogels.

Biomedical materials (Bristol, England)·2025
Same author

Risk of Malignancy Ranges and Category Percentage Assignment in Cytopathology Reporting Systems: Are They Useful Quality Assurance Indicators?

Acta cytologica·2025
Same author

Application of the triple diagnosis technique to endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic lesions: Impact on diagnostic accuracy and positive and negative predictive values.

Journal of the American Society of Cytopathology·2025
Same author

Fourth Cytopathology Monograph and Atlas Series Book Titled "Cytopathology of Urine (& The Paris System)" as Extension of Open Access Charter of Cytopathology Foundation Inc.

CytoJournal·2025
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
See all related articles

Telangiectatic osteosarcoma, a rare bone cancer variant, presents as destructive lytic lesions. Accurate diagnosis requires distinguishing it from aneurysmal bone cysts through detailed imaging and microscopic analysis.

Area of Science:

  • Oncology
  • Radiology
  • Pathology

Background:

  • Osteosarcoma is a prevalent primary malignant bone tumor in pediatric and adolescent populations.
  • Telangiectatic osteosarcoma constitutes an uncommon subtype, accounting for 3% to 10% of all osteosarcomas.
  • Radiographic presentation of telangiectatic osteosarcoma mimics aneurysmal bone cysts, posing diagnostic challenges.

Purpose of the Study:

  • To review the key diagnostic features of telangiectatic osteosarcoma.
  • To discuss differential diagnostic considerations, particularly distinguishing it from aneurysmal bone cysts.
  • To outline current treatment options and prognostic implications for telangiectatic osteosarcoma.

Main Methods:

  • Review of diagnostic imaging characteristics of telangiectatic osteosarcoma.

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Related Experiment Videos

Last Updated: May 22, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

  • Analysis of histopathological findings for differentiation from benign mimics.
  • Compilation of information on therapeutic strategies and patient outcomes.

    • Main Results:

    • Telangiectatic osteosarcoma exhibits purely lytic destructive lesions in long bone metaphyses.
    • Microscopic examination reveals dilated, blood-filled spaces with atypical stromal cells and potential osteoid matrix.
    • Differential diagnosis requires careful radiological and pathological assessment to exclude aneurysmal bone cysts.

    Conclusions:

    • Accurate differentiation of telangiectatic osteosarcoma from aneurysmal bone cysts is crucial for appropriate management.
    • Histopathological features, including the presence of atypical stromal cells, are key diagnostic indicators.
    • Understanding treatment options and prognostic factors is essential for optimizing patient care in telangiectatic osteosarcoma.